Back to Search
Start Over
Lowered zinc and copper levels in drug-naïve patients with major depression: Effects of antidepressants, ketoprofen and immune activation.
- Source :
-
World Journal of Biological Psychiatry . Feb2020, Vol. 21 Issue 2, p127-138. 12p. - Publication Year :
- 2020
-
Abstract
- Objectives: The aim of the present work is to examine the effects of treatment with sertraline with and without ketoprofen on serum levels of zinc and copper in association with immune-inflammatory biomarkers in drug-naïve major depressed patients. Methods: We measured serum zinc and copper, interleukin (IL)-1β, IL-4, IL-6, IL-18, interferon-γ, and transforming growth factor-β1 in 40 controls and 133 depressed patients. The clinical efficacy of the treatment was measured using the Beck Depression Inventory-II (BDI-II) at baseline and 8 weeks later. Results: We found significantly reduced serum zinc and copper in association with upregulation of all cytokines, indicating activation of the immune-inflammatory responses system (IRS) and the compensatory immune regulatory system (CIRS). Treatment with sertraline significantly increased zinc and decreased copper. During treatment, there was a significant inverse association between serum zinc and immune activation. The improvement in the BDI-II during treatment was significantly associated with increments in serum zinc coupled with attenuation of the IRS/CIRS. Conclusions: Lower zinc is a hallmark of depression, while increments in serum zinc and attenuation of the immune-inflammatory response during treatment appear to play a role in the clinical efficacy of sertraline. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 15622975
- Volume :
- 21
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- World Journal of Biological Psychiatry
- Publication Type :
- Academic Journal
- Accession number :
- 143137957
- Full Text :
- https://doi.org/10.1080/15622975.2019.1612090